Immunitybio, inc. class action alert: wolf haldenstein adler freeman & herz llp reminds investors that a securities class action lawsuit has been filed in the united states district court for the southern district of california against immunitybio, inc.

Lead plaintiff deadline is august 29, 2023 new york and san diego , july 14, 2023 /prnewswire/ -- wolf haldenstein adler freeman & herz llp  ("wolf  haldenstein") announces that a class action lawsuit has been filed against immunitybio, inc. ("immunitybio" or the "company") (nasdaq: ibrx) in the united states district court for the southern district of california, on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired immunitybio securities between may 23, 2022 and may 10, 2023, both dates inclusive (the "class period"). a ll investors who purchased shares and incurred losses are  advised  to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.
IBRX Ratings Summary
IBRX Quant Ranking